The beneficial effects of
Acanthopanax divaricatus var.
albeofructus (ADA) extracts have been assessed by mutagenic and anti-mutagenic activities by Ames test. Mutation of
Salmonella typhimurium strains TA 98, TA 100, TA1535, TA1537, and
Escherichia coli WP2
uvr A
was assayed in duplicates by the procedure of
Maron
and Ames in the
presence or absence of S9 mix. As a result, ADA extracts were not mutagenic for
S. typhimurium strains TA 98, TA 100, TA1535, TA1537, and
E. coli by the Ames assay. Anti-mutagenic activity was assayed by the Ames mutagenicity assay using histidine mutant of
S. typhimurium strains TA 98 and TA 100, using the plate-incorporation method. 2-Aminoanthrancene (2-AA), 2-(2-furyl)-3-(5-nitro-2-furyl) acrylamide (AF-2), and sodium azide (NaN
3) were used as the mutagens. ADA extracts showed a strong anti-mutagenic activity against 2-AA-induced mutagenesis which requires liver-metabolizing enzymes, and the same extract exhibited inhibitory effects on AF-2 and NaN
3-induced mutagenesis in the absence of liver-metabolizing enzymes. The data indicate that ADA
extracts contain anti-mutagenic activities against typical mutagens. The anti-mutagenic property of ADA provides additional health supplemental value to the other claimed therapeutic properties of the plant.
抄録全体を表示